Pressure Biosciences (PBIO)
US Market

Pressure Biosciences Financial Statements


Pressure Biosciences Financial Overview

Pressure Biosciences's market cap is currently ―. The company's EPS TTM is $-2.103; its P/E ratio is -0.61; Pressure Biosciences is scheduled to report earnings on November 16, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 498.14K$ 480.00K$ 315.20K$ 518.37K$ 608.93K
Gross Profit$ 196.00K$ 165.64K$ 143.92K$ 260.19K$ 322.27K
EBIT$ -1.08M$ -1.66M$ -953.68K$ -1.62M$ -1.22M
EBITDA$ -1.05M$ -1.63M$ -927.08K$ -1.59M$ -1.19M
Net Income Common Stockholders$ -3.35M$ -4.67M$ -4.30M$ -6.20M$ -5.15M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 18.54K$ 46.63K$ 50.53K$ 94.75K$ 118.80K
Total Assets$ 2.89M$ 2.89M$ 2.83M$ 3.33M$ 2.31M
Total Debt$ 8.46M$ 9.30M$ 11.93M$ 13.05M$ 13.57M
Net Debt$ 8.44M$ 9.25M$ 11.88M$ 12.96M$ 13.45M
Total Liabilities$ 30.10M$ 27.64M$ 25.04M$ 23.31M$ 24.61M
Stockholders Equity$ -27.21M$ -24.75M$ -22.21M$ -19.98M$ -22.30M
Cash Flow
Free Cash Flow$ -1.25M$ -757.42K$ -903.11K$ -1.99M$ -853.71K
Operating Cash Flow$ -1.24M$ -756.28K$ -784.67K$ -1.99M$ -853.71K
Investing Cash Flow$ -3.75K$ -1.14K$ -118.44K$ -541.00$ 0.00
Financing Cash Flow$ 1.25M$ 743.91K$ 371.77K$ 2.61M$ 849.81K
Currency in USD

Pressure Biosciences Earnings and Revenue History

Pressure Biosciences Debt to Assets

Pressure Biosciences Cash Flow

Pressure Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis